North China Pharmaceutical Company.,Ltd. Posted 678.8 Million Yuan Net Loss in 2022

North China Pharmaceutical Company.,Ltd. (华北制药股份有限公司) (600812.SH) reported a net loss of 678.8 million yuan in 2022, reversing a net profit of 35.4 million yuan for the previous year.

Meanwhile, the company posted 10.5 billion yuan in revenue, up 1.1% year-on-year.

At the end of the reporting period, it had 21.2 billion yuan in total assets and 15 billion yuan in total liabilities, with a liability-to-asset ratio of 70.7%.